Author(s): Stephen Doral Stefani ; Vanessa Teich ; André Poisl Fay ; Marcia Abadi ; Scott Flanders ; Cat Bui ; Andre Sasse
Date: 2022
Persistent ID: https://hdl.handle.net/10923/21670
Origin: Oasisbr
Document details
Cost of preventing an event (COPE) of enzalutamide versus abiraterone plus prednisone in men with metastatic castration-resistant prostate cancer under the Brazilian private health care system perspective
Description
Submitted by Biblioteca Suporte PUCRS (biblioteca.suporte@pucrs.br) on 2022-05-17T19:51:44Z No. of bitstreams: 2 Cost_of_preventing_an_event_COPE_of_enzalutamide_versus_abiraterone_plus_prednisone_in_men_with_metastatic.pdf: 299600 bytes, checksum: bea8ad627ce42d0268f5406c10dba0aa (MD5) Cost_of_preventing_an_event_COPE_of_enzalutamide_versus_abiraterone_plus_prednisone_in_men_with_metastatic.pdf: 299600 bytes, checksum: bea8ad627ce42d0268f5406c10dba0aa (MD5)
Made available in DSpace on 2022-05-17T19:51:44Z (GMT). No. of bitstreams: 2 Cost_of_preventing_an_event_COPE_of_enzalutamide_versus_abiraterone_plus_prednisone_in_men_with_metastatic.pdf: 299600 bytes, checksum: bea8ad627ce42d0268f5406c10dba0aa (MD5) Cost_of_preventing_an_event_COPE_of_enzalutamide_versus_abiraterone_plus_prednisone_in_men_with_metastatic.pdf: 299600 bytes, checksum: bea8ad627ce42d0268f5406c10dba0aa (MD5) Previous issue date: 2015
Document Type
Journal article
Language Portuguese
Language Portuguese
